Glutathione-S-transferase enhances proliferation-migration and protects against shikonin-induced cell death in breast cancer cells  by He, Shiping et al.
Kaohsiung Journal of Medical Sciences (2011) 27, 477e484ava i lab le at www.sc iencedi rec t .com
journa l homepage : ht tp : / /www.k jms-on l ine .comORIGINAL ARTICLE
Glutathione-S-transferase enhances
proliferation-migration and protects against
shikonin-induced cell death in breast cancer cellsShiping He a, Tsai-Tsen Liao a, Yi-Ting Chen a, Hsiu-Maan Kuo b, Ya-Ling Lin b,*aDepartment of Biological Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan
bDepartment of Parasitology, School of Medicine, China Medical University, Taichung, Taiwan
Received 26 October 2010; accepted 11 April 2011
Available online 25 August 2011KEYWORDS
Detoxification;
Glutathione-S-
transferase (GST);
Migration;
Proliferation;
Shikonin* Corresponding author. Department
E-mail address: ylin@mail.cmu.edu
1607-551X/$36 Copyright ª 2011, Else
doi:10.1016/j.kjms.2011.06.010Abstract Glutathione-S-transferase (GST) is a cytoplasmic protein responsible for detoxifica-
tion, but the effect of the enzyme on cell biological events, including proliferation and migra-
tion, has never been reported. Thus, we evaluated the detoxification effect of in vitro
eapplied GST on cancer cell proliferation and migration. Assays for proliferation and migration
of human breast cancer cells in the presence of GST were carried out. Binding of GST on the
surface of the cancer cells was studied by flow cytometry. Detoxification through GST pathway
was studied in the presence of shikonin. The effective dosage of GST in enhancement of cell
proliferation was 10e50 nM, and the cell migration could be significantly enhanced after 6
hours in the presence of 2e50 nM GST. Therefore, overall cell proliferation and migration could
be enhanced in the presence of 10 nM or greater concentration of GST, and 15 mM shikonin-
induced toxification of the cancer cells could be neutralized by 1.0 mM GST. Flow cytometry
showed that GST directly bound to the surface of the cancer cells, and this was confirmed
by fluorescence confocal microscopic observation. It is concluded that human class p-GST
enhances proliferation and migration of human breast cancer cells by means of direct binding
to the cell surface and maintaining cell viability by detoxification.
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.Introduction
Glutathione-S-transferase (GST) is a dimer that shares
homology in almost all eukaryotes and plays a role inof Parasitology, School of Medici
.tw (Y.-L. Lin).
vier Taiwan LLC. All rights reservinternal cell detoxification. Recently, it was found that GST
might neutralize toxic effects caused by drugs, food addi-
tives, environmental chemicals, and carcinogens [1e3]. A
few copies of gst genes are located in human chromosomesne, China Medical University, Taichung 40402, Taiwan.
ed.
478 S. He et al.6p encoding for a-GST, 1p for m-GST, 11q for class p-GST
(p-GST), and 22q for q-GST [4e7]. The natural substrate
of GST is glutathione, a water-soluble molecule widely
present as both oxidized and reduced (GSHRed) forms in
eukaryotes. Binding of GSHRed with GST causes oxidation of
the substrate and, thus, maintains the balance of redox
states in cells [8].
Internal detoxification by means of GST occurs in
conjugation pathway (Phase II), in which GST binds with
substrates forming conjugates, such as GSH S-conjugate.
The conjugate is then catalyzed to cysteine S-conjugate by
g-glutamyl transpeptidase and is finally released in feces
and urine [9,10].
It is well known that free radicals, including hydrogen
peroxide, superoxide anion, and hydroxyl radicals, are
toxic substances generated in electron transfer pathways
in mitochondria, especially under the stimulation of UV
light. Excess amounts of these radicals cause damage
to the cells, including large-molecule nucleic acids,
proteins, and lipids [11]. More severe radicals, such as
alkoxy radical and a,b-unsaturated aldehydes, may be
generated readily when lipid is attacked by hydroxyl
radical and singlet oxygen, causing high oxygen pressure
in cells [12]. GST plays an important role in neutralizing
these radicals, decreasing accumulation of fatty acid
hydroperoxides and phospholipid hydroperoxides, and
preventing the production of a,b-unsaturated aldehydes
in the cells [13,14].
Antiapoptic effects of GST had been reported in leukemia
K562 cell line, which expressed large amounts of human a-
GST. The enzyme inhibited the activation of stress-activated
protein kinase/c-jun N-terminal kinase and caspase-3. Thus,
GST prevents apoptosis probably by decreasing superoxide
anion under high oxygen pressure [15].
Shikonin is a natural substance of Radix arnebiae,
a herbal drug used very often in the treatment of immune-
mediated diseases, including systemic lupus erythematosis
and cancers. This herbal drug was first listed as a middle-
grade drug in Shen Nong’s Herbal Classics, the earliest
extant monograph on material medica in China, which
appeared about 2020 years ago (during Qin and Han
Dynasties). Recently, shikonin was found to inhibit bacterial
growth [16,17], suppress replication of HIV [18] and
inflammation [19], and inhibit platelet aggregation [20,21].
Shikonin was also found to enhance apoptosis of cancer
cells [22]. Our preliminary results also showed that shikonin
was toxic to human breast cancer cells under culture
conditions.
Our previous experimental results showed that exoge-
nous application of Schistosomiasis japanicum GST to
human breast cancer cell line (MDA-MB-435s) could
enhance proliferation and migration by stimulating over-
expression of matrix metalloproteinases 2 and 9 [23]. To
reveal GST the detoxifying mechanism of action in cancer
cell proliferation and migration against used shikonin as
cellular toxic substance, we set up the current experiments
applying recombinant human p-GST to incubate with MDA-
MB-435S cells and used flow cytometry and confocal
microscope to detect the binding of GST with MDA-MB-435s
cells. Our present results provide some molecular insights
of GST on proliferation, migration, and extracellular
detoxification in human breast cancer cells.Methods
Reagents
Recombinant Taq DNA polymerase with proofreading
activity, polymerase chain reaction buffer, deoxyribonu-
cleotide triphosphate mix, and restriction enzymes were
purchased from TaKaRa (Tokyo, Japan). The intermediate
polymerase chain reaction cloning kit (pGEM-T easy vector
system) was obtained from Promega (Madison, WI, USA),
and expression vector (pAcGFP-N1) was purchased from
Invitrogen (San Diego, CA, USA). General chemicals were
purchased from Sigma (Shanghai, China).
Purification of GST
Expression plasmid was constructed with prokaryotic cell
expression vector pKK233-2 containing p-GST gene.
Recombinantp-GST (rGST) was purified fromp-plasmid GST-
transformed Escherichia coli strain JM109. Briefly, 100 mL of
fresh Luria Broth medium containing 10 g/L tryptone, 5 g/L
yeast extract, 10 g/L NaCl, and 80 mg/mL ampicillin was
inoculated with p-plasmid GST-transformed Escherichia coli
strain [BL21 (DE3)] and was grown overnight at 37C with
vigorous shaking. The stock cells were then transferred to
900 mL of fresh Luria Broth medium containing the same
concentration of antibiotic and continued to grow for 2 hours
before IPTG was added to the final concentration of 0.3 mM
to induce gene expression. The growth was maintained for
another 4 hours, cells are harvested, sonicated, in solubili-
zation [50 mM Tris-HCl (pH 8.0)] was achieved by centrifu-
gation. The supernatant containing rGST was dialyzed
against 100-fold volume of phosphate-bufferred saline (PBS)
(140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 1.8 mM
KH2PO4); centrifuged to remove insoluble materials; filtered
through 0.45-mm membrane; and then loaded onto
glutathione-agarose column equilibrated with PBS. The
column was washed in 5e10 bed volumes of PBS or until zero
absorbance at 280 nm. The recombinant protein was eluted
in elution buffer (10-mM GSHRed in Tris-HCl, pH 8.0), and
protein concentration was estimated spectrophotometri-
cally [24], used immediately or stored at 80C until use.
Cell viability assays
The measurement of viability was based on the ability to
cleave tetrazolium salts by dehydrogenases [25]. Augmenta-
tion in the amount of developed color directly correlatedwith
the number of metabolically active cells. Assays
were performed according to manufacturer’s instructions
(Roche Molecular Biochemical, Indianapolis, IN, USA). Cells
were seeded in96-well plates at adensity of 5 104 cells/well
in culture medium for 4 hours to allow attachment. The cell
viabilityedetecting reagent 4-[3-(4-lodophenyl)-2-4(4-
nitrophenyl)-2H-5-tetrazolio-1,3-benzene disulfonate] (WST-
1; 10-mL pure solution) was added to each sample after every
treatment with various concentrations of shikonin, and the
cells were incubated for another 2 hours in a humidified
atmosphere (37C). The absorbance of the samples (A450) was
determined using a scanning multiwell spectrophotometer.
Absolute optical density was normalized to the absorbance of
Figure 1. Microscopic view of proliferation of MDA-435S cells in the presence of GST and HGF. Concentrations of GST and HGF
were 50 nM and 2 nM, respectively. The cells were stained by crystal violet, air dried, and recorded under reversed microscope
(200). GSTZ glutathione-S-transferase; HGFZ hepatocyte growth factor.
GST against shikonin-induced cell death 479unstimulated cells in each plate and was expressed as
a percentage of the control value. Shikonin concentration
causing about 50% viability was chosen for detoxification
assays in the presence of rGST. Experiments were repeated
five times in six replicates (wells).Figure 2. Proliferation assays for the growth of human breast
cancer cells in the presence of various concentrations of
recombinant class Pi glutathione-S-transferase. Absorbance was
recordedonDay 0, Day 2, Day 4, Day 6, andDay8 in thepresence of
2 nMHGFand2 nM,5 nM,10 nM,50 nM,and100 nMof recombinant
classPiglutathione-S-transferase.MDAcontrol contained100 nMof
human albumin. *p< 0.05, **p< 0.01, and ***p < 0.005 compared
with themediumcontrol oreachother (nZ 6).GSTZ glutathione-
S-transferase; HGFZ hepatocyte growth factor.
Figure 3. Absorbance of proliferation assays for the growth
of human breast cancer cells in the presence of GSHRed and
recombinant class Pi glutathione-S-transferase (rGST). Assays
were carried out in the presence of various concentrations of
rGST and GSHRed, and absorbance at 570 nm was recorded. The
treatments (nZ 6) in each assay were carried out in medium
control containing 10 nmol/L of human albumin (MDA); 10 nM of
GSHRed; mixture of 10 nM of GSHRed and rGST (GSTþGSHRed);
and 10 nM of rGST (GST). Cells were stained with crystal
violet, and the absorbance was measured at 570 nm. **p< 0.01
compared with the medium control. GSHRedZ reduced gluta-
thione; GSTZ glutathione-S-transferase.
Figure 4. Photographic records on MDA cell migration in the presence of recombinant class Pi glutathione-S-transferase. The
first-line photographs indicate the initial stage of migration (0 hour). The second, third, and fourth lines of the photographs show
the cell migration after 6-hour, 12-hour, and 24-hour incubation, respectively, in the presence of recombinant class Pi glutathione-
S-transferase. Cells were stained with crystal violet and recorded under reversed microscope.
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The assays were carried out similarly as we described
[26,27]. Briefly, MDA-MB-435S cells were seeded in BD
Falcon 96-well culture plates (BD Biosciences, Taipei,
Taiwan) at a density of 1500 cells/well and cultured in
complete growth medium at 37C in air in the presence of
various concentrations of rGST. The culture medium
(100 mL/well) was replaced with fresh rGST every 2 days. At
Day 2, Day 4, Day 6, and Day 8, cells were harvested, fixed,
and stained with 0.2% crystal violet for 15 minutes and
destained with double-distilled water. The plate was air
dried and recorded (with photographs), and the dye was
solubilized with 1% sodium dodecyl sulfate (100 mL/well) by
incubation at 37C for 1 hour. Absorbance of the solubilized
stain was measured at 570 nm using a calibrated Model 5500
Microplate Reader (Bio-Rad, Hercules, CA, USA).
Wound-healing assays
Migration assays were carried out according to earlier
reports [26,28] for the different concentrations of GST in BD
Falcon 24-well culture plate. The cells were seeded in the
plate wells with or without 1-mm tape stuck in the middle
and grown to 100% confluency. Then, the tape was taken outto make the wound area, or the cell layer was scratched in
the middle of the wells using yellow tips, washed three
times with serum-free medium, and the cells were grown
further in 1% fetal calf serum-supplemented medium con-
taining 0.01 mg/mL human insulin (Gibco, Oxford, UK) at
37C. The wounded monolayer of culture was recorded
under inverted microscope at 0 hour, 6 hours, 12 hours, 24
hours, 36 hours, and 48 hours, and the migrated cell
numbers were counted from the camera records.
Flow cytometry
Flow cytometry was carried out to determine the binding of
rGST with human breast cancer cells [29] with slight modi-
fication. Briefly, cells were transferred to fresh tube
(2 105/tube) and collected by centrifugation at 1500 rpm
for 3 minutes. The cells were washed with PGB (PBS con-
taining 20 mM glucose and 5% bovine albumin); centrifuged;
and then 100 mL PGB containing 0 nM, 200 nM, and 500 nM of
rGSTwas added. The cells were incubated on ice for 1 hour,
and then unbound rGST was washed off in PGB for three
times before rabbit anti-GST (Immunology Consultants
Laboratory, Inc., Newberg, OR, USA) was added (1:1,000)
and incubated on ice for 1 hour. Unbound (free) anti-GSTwas
washed off with PBS for three times, and goat anti-rabbit Ig
Figure 5. Quantification of absorbance of migration assays
for motogenesis of human breast cancer cells in the presence of
recombinant class Pi glutathione-S-transferase. Migrated cell
numbers were accounted from the 6th hour, 12th hour, 24th hour,
36th hour, and 48th hour of culture. The treatments (nZ 10) in
each assay were carried out in medium control containing 50 nM
of human albumin (MDA) and 2 nM, 5 nM, 10 nM, and 50 nM of
recombinant class Pi glutathione-S-transferase. Migrated cells
were quantified in square centimeters. *p< 0.05 and **p< 0.01
compared with the medium control or each other.
Figure 6. Assays for detoxification by recombinant class Pi
glutathione-S-transferase (rGST) in the presence of shikonin
human breast cancer cells. (A) Assays (nZ 6) for LD50 of shikonin
in MDA-MB-435S in various concentrations: 2 mM, 5 mM, 10 mM,
25 mM, 50 mM, and 100 mM of shikonin. The LD50 of shikonin was
about 15 mM. (B) Assays (nZ 6) for the protection of MDA-MB-
435S cells in the presence of rGST. Bars 1 and 2 are MDA and
dimethyl sulfoxide controls, respectively, and Bars 3e8 are
assays in the presence of 10 mM of shikonin with no rGST (Bar 3),
0.5 mM rGST (Bar 4), 1.0 mM rGST (Bar 5), 2.0 mM rGST (Bar 6),
5.0 mMrGST (Bar 7), and10.0 mMrGST (Bar 8). LD50Z lethal dose,
50%; rGSTZ recombinant class Pi glutathione-S-transferase.
GST against shikonin-induced cell death 481conjugated with FITC (1:1000) (Chemicon International,
Inc., Temecula, CA, USA) was added, incubated, and washed
in PBS as described earlier. Finally, the cells were read by
flow assorted scan cytometry (BD Biosciences).
Binding of GST with MDA-MB-435S
Binding of GST with MDA-MB-435S was carried out similarly
as we reported [23]. Briefly, recombinant human p-GST
(100 nM, 200 nM, and 500 nM) was added to detached
MDA-MB-435S, mixed, and incubation at room temperature
was carried out for 30 minutes. Then, the cells were
washed three times with PBS to remove free rGST, and
then 10 nM of anti-GST conjugated with fluorescing
substance (Santa Cruz, CA, USA) was added and incubated
at room temperature for 30 minutes. This was followed by
three washes in PBS and then viewed under fluorescence
microscope.
Statistical analysis
Statistical difference was determined with Student t test
and one-way analysis of variance. A p value less than 0.05
was considered statistically significant.
Results
rGST enhanced proliferation of MDA
Assays for proliferation of human breast cancer cell line
(MDA-435S) showed that rGST significantly enhanced cell
growth at the concentration of 10 nmol/L or higher in the
fourth-day assay (Fig. 1). In contrast, however, when theconcentration of rGST was increased from 50 nM to 100 nM
or higher, proliferation was not shown to be significantly
enhanced, suggesting the functional concentration range in
our assay system. Moreover, 2 nM of hepatocyte growth
factor was detected to enhance cell growth significantly
compared with MDA control, but 2 nM of rGST did not seem
to promote cell growth significantly throughout the test; on
the other hand, 5 nM of rGST exhibited lower stimulation
with no significant effect until the sixth-day assay
compared with MDA control, suggesting insufficient dosage
to stimulate cell growth below 10 nM rGST in our assays.
These results (Fig. 2), therefore, clearly showed that rGST
stimulated MDA growth, but fivefold greater concentration
was required for significant enhancement than that of
hepatocyte growth factor in comparison with the medium
control, suggesting different receptors and probably
different pathways.
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MDA growth
To understand if GSHRed binding site of GST is required for
cellular stimulation, we carried out another assay in the
presence of GSHRed. Results showed that GSHRed alone had
no stimulation effect on the cell growth throughout the
assay compared with the MDA control, nor did the premixed
10 nM of rGST and GSHRed. It was clear, therefore, that GST
with free binding site was required for the enhancement of
MDA proliferation from the fourth-day assay compared with
GSHRed, mixture of GSHRed and GST, and MDA control, and
this was maintained to the end of the assay (Fig. 3).
MDA cell migration was enhanced in the presence
of rGST
Migrated cells in wells of BD Falcon 24-well culture plate
could be fixed and stained for direct observation under
reversed microscope. The number of migrated cells began
to increase within 6 hours of culture in the absence or
presence of rGST, but the number was significantly greater
in the presence of rGST than MDA control. Moreover,
significantly increased cell numbers could be observed even
in the presence of 2 nM of rGST compared with the MDA
control. In contrast, 2 nM of rGST did not seem to stimulateFigure 7. Separation of MDA-MB-435S in the presence or absenc
FASC. (A) Separation of MDA cells in the absence of rGST and in
followed by goat anti-rabbit Ig conjugated with FITC. (B) Separa
rabbit anti-GST and then goat anti-rabbit Ig conjugated with FITC. (C
by rabbit anti-GSTand goat anti-rabbit Ig conjugated with FITC. (D) Se
rabbit anti-GST and goat anti-rabbit Ig conjugated with FITC. (E) Sep
rabbit anti-GST and goat anti-rabbit Ig conjugated with FITC. All cells
and each chart was constructed with scanning of 10,000 cells. FASCMDA proliferation throughout the tests as measured by
absorbance at 570 nm, suggesting that direct microscopic
observation (Fig. 4) is more sensible than indirect spec-
troscopic absorbance. Migrated cell number was counted
and calculated as cell number/mm2, the data of which are
plotted in Fig. 4, showing that cell motorgenesis seemed to
be more reactive in the presence of rGST even at lower
concentrations, such as 2 nM, so that more cells were
shown to migrate to the wounding area compared with
those with the MDA control (Fig. 5). Although cell migration
in 2 nM of rGST was lower than that in the presence of
50e100 nM of rGST, the difference was not statistically
significant.
Recombinant GST protected shikonin-induced cell
death
To determine the lethal dose, 50%, of shikonin to MDA in 24-
hour culture, we titrated shikonin concentration from 2 mM
to 100 mM and found that the lethal dose, 50%, was about
15 mM (Fig. 6A). A series of rGST concentrations (0.5 mM,
1.0 mM, 2.0 mM, 5.0 mM, and 10.0 mM) were used to mix with
15 mM of shikonin in MDA cell culture for 24 hours. Results
(Fig. 6B) showed that 1 mM or greater concentration of rGST
could effectively prevent cell death caused by 15 mM of
shikonin.e of recombinant class Pi glutathione-S-transferase (rGST) by
the presence of rabbit anti-glutathione-S-transferase (GST),
tion of MDA cells in the presence of 5 nM rGST followed by
) Separation of MDA cells in the presence of 10 nM rGST followed
paration of MDA cells in the presence of 100 nM rGST followed by
aration of MDA cells in the presence of 200 nM rGST followed by
under the treatments were separated by FASC (BD Biosciences),
Z flow assorted scan cytometry.
GST against shikonin-induced cell death 483Binding of rGST to the surface of MDA
To understand the mechanism of action of rGST in cell
proliferation and migration, flow cytometry was carried out
to determine the interaction between rGST and MDA cells.
Results (Fig. 7) showed that most of the cells (99.9%) with
weak FITC gathered together to form a narrow peak in the
absence of rGST (Fig. 7A), and only a tiny fraction of cells
(0.1%) was spread with stronger FITC. When rGST (5 nM)
was added, however, cells were significantly separated into
two groups: one with weaker FITC consisting of 79.3% cells
and another with stronger FITC consisting of 20.7% cells
(Fig. 7B). In addition, when 10 nM GST was added, weaker
FITC cells were about 76.9%, whereas stronger FITC cells
increased to 23.1% (Fig. 7C). Moreover, when 100 nM GST
was added, weaker FITC cells decreased to 56.4% and
stronger FITC cells increased to 43.6% (Fig. 7D). When GST
concentration was further increased to 200 nM, weaker
FITC cells decreased to 43.5%, whereas stronger FITC cells
increased to 56.5% (Fig. 7E). To confirm the binding of
human rGST with MDA-MB-435S, human rGST was used toFigure 8. Binding of human class Pi glutathione-S-
transferase with MDA-MB-435S. (A) (100) MDA-MB-435S cells
were directly bound with anti-GST-fluorescein, washed, and
then observed under fluorescence microscope. No fluorescence
was emitted from the cells. (B) (100) When MDA-MB-435S
cells were incubated with human class Pi glutathione-S-
transferase followed by anti-GST-fluorescein, strong fluores-
cence could be observed.bind with the cancer cell. Anti-GST conjugated with fluo-
rescing substance was added to bind with rGST. Control
experiment without rGST was carried out. As expected, our
results showed that anti-GST-fluorescein did not bind
directly with MDA-MB-435S, but anti-GST-fluorescein bound
well if GST was added first to the cells. Binding of GST with
MDA-MB-435S could be observed directly under fluores-
cence microscope (Fig. 8).Discussion
Internal cytoplasmic detoxification by means of GST has
been reported to occur at Phase II in detoxification pathway
[8,9], protecting cells from damage by free radicals.
Detoxification occurring in cytoplasmic space can be
divided into two phases: (1) Toxic substances may be bound
with cytochrome P450 and turned into intermediates and
(2) In Phase II, GST binds and turns the intermediates into
nontoxic substances, which are then released through
drainage systems. To determine if detoxification of GST
enhances cell proliferation and the mechanism of action of
GST in migration, the present study was, therefore, carried
out to examine the molecular action of rGST in cancer cells.
First, we used a wide range of rGST concentrations
(2e100 nM) in cellular assays for proliferation of human
breast cancer cells and found that 50e100 nM of GST made
no significant difference in the enhancement of cell
proliferation, but 5e50 nM of GST exhibited significant
enhancement, suggesting a functional stimulating concen-
tration range (5e50 nM) and saturating concentration range
of GST (50e1000 nM) in our assay system.
Second, when 10 nM of GSHRed, a natural substrate of
GST and an internal cell free radical, was added in the
medium, it was shown that this free radical did not do any
harm to the cells. However, when GSHRed was premixed
with the same concentration of rGST, the GST-stimulating
activity was lost, suggesting that a free binding site of
GST is required for the stimulation activity.
Third, cell migration in the presence of rGST was shown
to be stimulated significantly from 2 nM to 50 nM but was
not further enhanced at higher concentration range
(50e200 nM) compared with the that in MDA control con-
taining 50 nM of human albumin. These results suggested
a link between GST and GST receptor, and only limited
working concentration of GST was required in stimulating
the cell function.
Furthermore, toxicity study showed that GST could carry
out detoxification in the presence of shikonin, which was
shown to cause apoptosis of cancer cell [22], and on direct
contact, kill cancer cells. It was, therefore, used in our
present study to examine the effect of GST’s detoxification.
Our results showed that the toxic effect of 15 mM shikonin
on MDA could be prevented by 1.0 mM rGST, suggesting that
one GST may bind with more than one shikonin.
Finally, to study the mechanism of action of rGST in
enhancement of cell proliferation and migration in the
absence of toxic substance, we used flow cytometry to
determine if GST directly bound to the cell surface. Our
results strongly showed that the interaction between rGST
and MDA cells held truth, and therefore, a second peak with
stronger FITC was produced (Fig. 7). Unlike the functional
484 S. He et al.assays, however, higher concentration of GST, for instance,
up to 200 nM GST, resulted in higher percentage of binding
cells with weaker FITC, suggesting a difference between
functional and structural concentrations of GST. To confirm
cytometry results, we designed another experiment that
allowed human rGST to bind with the surface substance on
MDA-MB-435S cells and then anti-GST-fluorescein to reveal
the site of S japanicum GST. Observation with fluorescence
microscope showed that it was indeed bound well on the
surface of MDA-MB-435S (Fig. 8). We believe that there is
likely a GST receptor on the surface of MDA-MB-435S cells.
Results from proliferation and migration assays and flow
cytometer binding assays suggested that some GST bound
to the cell surface exhibited no growth or migration signals.
Dimeric shikonin and three-dimensional structure of
p-GST had been determined by nuclear magnetic resonance
spectroscopy [30] and crystallography [31]; our shikonin-
GST binding assays suggested that a homology dimer GST
might bind with 20 monomeric or 10 dimeric shikonins.Acknowledgments
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